Hassan Fred (CIK 1110744) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Buy PGEN (71,839 shares), Buy PGEN (17,948 shares), Buy COCP (359,713 shares), Buy BBIO (6,589 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-03-16 | PRECIGEN, INC. (PGEN) | Director | Buy | 71,839 | $0 |
| 2026-03-12 | PRECIGEN, INC. (PGEN) | Director | Buy | 17,948 | $62,997 |
| 2025-10-30 | Cocrystal Pharma, Inc. (COCP) | Director | Buy | 359,713 | $500,001 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-03-17 | PRECIGEN, INC. (PGEN) | Director | Buy | 36,206 | $62,998 |
| 2025-03-17 | PRECIGEN, INC. (PGEN) | Director | Buy | 87,412 | $0 |
Source: SEC Form 4 filings · as of 2026-06-24